&w=3840&q=100)
Israel's RedC wants to turn donor cells into $50 shelf-ready blood
Surajeet Das Gupta New Delhi
Listen to This Article
In the next five to six years, you might be able to buy laboratory (lab)-grown blood off the shelf for just $50 a unit, compatible with all blood types.
An Israel-based company, RedC Biotech, is working towards that goal. It is developing a process that reprogrammes blood from universal donors (O-negative) by deactivating genes in the white blood cells, converting them into stem cells. These are then harvested and multiplied in large bioreactors capable of producing 2,000 litres of red blood cells, using technology developed by the Technion — Israel Institute of Technology.
Although RedC has already produced small quantities
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
32 minutes ago
- Time of India
When 9 pm dinners clash with 7 am work: How urban lifestyles are dragging you and your kids into a dangerous health crisis
What was once brushed off as an adult complaint is now becoming a teenage crisis: sleepless nights, foggy mornings, and exhausted days. Anand, an 18-year-old computer science student, recalls how his days began with fatigue rather than energy. Tossing and turning until sunrise, he would finally drift off at 5 or 6 am, only to miss his 9 am classes. His memory dulled, assignments piled up, and grades suffered. 'I'd be wide awake when I needed to be sleeping, and then utterly exhausted when I had to be alert and learning. It felt like I was fighting my own body,' Anand told TOI. He was later diagnosed with Delayed Sleep Phase Syndrome (DSPS), a disorder that disrupts the body's internal clock. Urban Lifestyle Fuelling Disorders According to Dr Garima Shukla, professor of neurology at Queen's University, Canada, formerly at AIIMS Delhi, 'Urban lifestyles are a perfect storm for sleep diorders. There is late-night device use, academic demands, and irregular meal timings, often dinners as late as 9 or 10 pm, that disrupt natural sleep cycles, unlike the West where meals are eaten between 5 and 7pm, aiding better sleep,' she told TOI. Youngsters also indulge in late-night snacking while studying or scrolling through their phones, further delaying sleep. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Access all TV channels anywhere, anytime Techno Mag Learn More Undo Dr Shaunak Ajinkya, consultant psychiatrist at Kokilaben Dhirubhai Ambani Hospital, recalled to TOI how one of his patients, 16-year-old Sabira, slept 12–13 hours a day yet woke up exhausted. Once a top student and guitarist, she withdrew from school and friends. After tests, including overnight polysomnography, she was diagnosed with mild depression and a circadian rhythm disorder. 'Her internal clock was misaligned with the environment outside, causing her body to want sleep at odd times and making it hard to feel truly rested,' he said. To reset her sleep cycle, Sabira was prescribed melatonin, a strict bedtime routine, and early exposure to sunlight. Her nights now involve no screens, no caffeine, and a calming wind-down ritual, as reported in TOI. Live Events Pressure of Early Classes A 2021 Kochi-based study in the International Journal of Contemporary Paediatrics reported a 5.7% prevalence of DSPS among adolescents. Another, by Verma et al. in 2002, highlighted how India's late-night studying habits combined with early school timings worsen the problem. Neurophysiologist Dr Hrudananda Mallick told TOI that shifting school start times could help. 'School timings force kids to wake early, cutting sleep short. In metros, shifting school start times, as done in California, could help,' he said. Japan has been experimenting too. Sunao Uchida, a physician with the Japanese Society of Sleep Research, described in TOI how an elementary school tested naptimes combined with maths lessons over seven months, showing improved focus. Beyond Teens: Even Toddlers Struggle The crisis is not confined to teenagers. Paediatric obesity has been linked to obstructive sleep apnoea (OSA). Dr Siddhant Lalwani, paediatric pulmonologist at Bharati Hospital, Pune, told TOI about a six-year-old boy whose oxygen levels dropped dangerously low at night due to OSA. 'He now sleeps well with the help of a CPAP machine, which we're increasingly using even in infants,' he said. Poor sleep, he warned, is linked to long-term risks like hypertension, metabolic disorders, and weak academic performance. Dr Shambhavi Joshi from Bharati Hospital's department of sleep medicine added: 'From toddlers to college students, hormonal shifts and lifestyle choices like staying up until 4 or 5 am wreak havoc on sleep cycles,' as quoted by TOI. Post-Covid, ENT surgeon Dr Sandeep Karmarkar at Ruby Hall Clinic, Pune, reported a sharp rise in sleep-related breathing issues among children due to enlarged adenoids. 'Cases have surged in the last four to five years, especially among kids aged five to eight. I recently treated a four-year-old who had never breathed properly through his nose. Timely surgery transformed his life in just two weeks,' he told TOI. Blue Light and Digital Burnout Experts also blame blue light from screens for disrupted sleep. 'It delays circadian rhythms, especially in kids and teens who ideally need 9–11 hours of sleep for growth,' Dr Mallick told TOI. Research shows that just four consecutive nights of five-hour sleep can impair performance similar to alcohol intoxication. Dr Ajinkya observed in TOI that post-Covid sleep complaints among youth have surged by 30%, with one in five reporting insomnia or sleep anxiety. 'Digital learning, stress, and less physical activity are key drivers,' he said. Inputs from TOI
New Indian Express
44 minutes ago
- New Indian Express
New malaria drug for babies offers hope to health workers in Uganda
KAMPALA: Alice Nekesa did not know she was infected with malaria-causing parasites until it was too late. She was in the fourth month of pregnancy last year when she started bleeding, a miscarriage later attributed to untreated malaria in her. The Ugandan farmer said recently that she regretted the loss of what would have been her second child 'because I didn't discover malaria and treat it early.' Variations of such cases are commonly reported by Ugandan health workers who witness stillbirths or feverish babies that die within days from undiagnosed malaria. The deaths are part of a wider death toll tied to the mosquito-borne disease, the deadliest across Africa, but one easily treated in adults who seek timely medical care. Until recently, a major gap in malaria treatment was how to care for newborns and infants infected with malaria who weren't strong enough to receive regular medication. That changed last month when Swiss medical regulators approved medicine from the Basel-based pharmaceutical company Novartis for babies weighing between 2 and 5 kilograms (nearly 4½ to 11 pounds). Swissmedic said the treatment, a sweet-tasting tablet that disperses into a syrup when dropped into water, was approved in coordination with the World Health Organization under a fast-track authorization process to help developing countries access much-needed treatment. Africa's 1.5 billion people accounted for 95% of an estimated 597,000 malaria deaths worldwide in 2023, according to the WHO. More than three-quarters of those deaths were among children.
News18
an hour ago
- News18
Natco Pharma launches generic drug with 180-day exclusivity in US
Agency: New Delhi, Aug 20 (PTI) Natco Pharma on Wednesday said it has launched a generic medication to treat high blood pressure in the lungs in the US with 180-day exclusivity. The company has launched Bosentan tablets for oral suspension (32 mg), a generic version of Tracleer tablets by Actelion Pharmaceuticals US Inc. Natco's marketing partner for the product is Lupin Ltd, the Hyderabad-based drug maker said in a regulatory filing. Natco holds the first-to-file status for this product and will have 180-day generic drug exclusivity, it added. The drug is indicated for the treatment of pulmonary arterial hypertension (PAH) in paediatric patients aged 3 years and older. Bosentan tablets for oral suspension (32 mg) had estimated sales of USD 10 million in the US for 12 months ended June this year, as per industry sales data, Natco Pharma stated. Shares of the drug firm were trading 0.53 per cent down at Rs 888.55 apiece on the BSE. PTI MSS MSS SHW view comments First Published: August 20, 2025, 14:30 IST Disclaimer: Comments reflect users' views, not News18's. Please keep discussions respectful and constructive. Abusive, defamatory, or illegal comments will be removed. News18 may disable any comment at its discretion. By posting, you agree to our Terms of Use and Privacy Policy. Loading comments...
